New York-based private equity firm Arsenal Capital Partners has promoted Eugene Gorbach to principal. The firm is focused on middle-market deals in specialty industrial and healthcare companies. Gorbach joined the firm in 2008.
Arsenal Capital Partners announced today the promotion of Eugene Gorbach to Principal of this leading New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies.
“Since he joined Arsenal in 2008, Gene has assumed increasing responsibilities and helped lead a number of key investments. Gene exemplifies the values of Arsenal. He works effectively with his colleagues and the management teams of our portfolio companies, where he has helped to build value. As we continue to strengthen our senior leadership team and build for the future, we are pleased to recognize Gene’s contributions and tangible achievements to the firm with this promotion,” said Terrence Mullen, Partner at Arsenal Capital.
Mr. Gorbach focuses on healthcare investments for Arsenal. He joined the firm as a Senior Associate in 2008 and was named Vice President in 2010. Mr. Gorbach joined Arsenal from American Capital Strategies, and prior to that served as an Associate with Madison Dearborn Partners and as an Analyst at J.P. Morgan Chase & Co. He currently serves on the Board of Directors of TractManager, the leading provider of contract compliance solutions to hospitals in the U.S., and The WIRB-Copernicus Group, the leading provider of clinical trial ethical review services. Mr. Gorbach received his B.A. degree from Dartmouth College and his M.B.A. degree from the Wharton School at the University of Pennsylvania.
About Arsenal Capital Partners
Arsenal Capital Partners is a leading New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies. Arsenal makes investments in sectors where the firm has significant prior knowledge and experience. Arsenal targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm’s operational improvement capabilities. Arsenal currently has over $1.5 billion of committed equity capital.